◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

Cytophage Technologies Ltd.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item FY 2024Dec 31, 2024 FY 2023Dec 31, 2023 FY 2022Dec 31, 2022 FY 2021Dec 31, 2021
Total Revenue 0.00 0.00 0.00 0.00
Operating Revenue 0.00 0.00 0.00 0.00
Selling General And Administration 4.3M 3.9M 708,428 2.9M
General And Administrative Expense 4.3M 3.9M 708,428 2.9M
Research And Development 22,868 441,854 442,614 424,832
Depreciation And Amortization In Income Statement 707,256 512,827 364,552 295,808
Other Operating Expenses 127,988 -101,900 83,816 -129,504
Operating Expense 5.2M 4.6M 792,244 3.2M
Operating Income -5.2M -4.6M -792,244 -3.2M
EBIT -7.8M -4.6M -792,244 -3.2M
Interest Expense 102,208 34,261 20,136 30,530
Interest Expense Non Operating 102,208 34,261 20,136 30,530
Interest Income 142,160 3,786 86,038 --
Interest Income Non Operating 142,160 3,786 86,038 --
Net Interest Income 39,952 -30,475 86,038 -30,530
Other Income Expense -2.7M -10,910 -41,866 --
Other Non Operating Income Expenses 11,251 -- -- --
Special Income Charges -2.8M -10,910 -- --
Earnings From Equity Interest -- -83,470 -41,866 --
Pretax Income -7.9M -4.6M -706,206 -3.2M
Tax Effect Of Unusual Items 0.00 0.00 0.00 0.00
Net Income From Continuing And Discontinued Operation -7.9M -4.6M -706,206 -3.2M
Net Income From Continuing Operation Net Minority Interest -7.9M -4.6M -706,206 -3.2M
Net Income Including Noncontrolling Interests -7.9M -4.6M -706,206 -3.2M
Net Income Common Stockholders -7.9M -4.6M -706,206 -3.2M
Net Income -7.9M -4.6M -706,206 -3.2M
EBITDA -7.1M -4.1M -792,244 -2.9M
Normalized EBITDA -4.3M -4.1M -792,244 -2.9M
Reconciled Depreciation 707,256 512,827 364,552 295,808
Basic EPS -0.15 -0.09 -0.01 -0.06
Diluted EPS -0.15 -0.09 -0.01 -0.06
Basic Average Shares 52.8M 53.8M 53.8M 53.8M
Diluted Average Shares 52.8M 53.8M 53.8M 53.8M
Total Unusual Items -2.8M -10,910 -- --
Total Unusual Items Excluding Goodwill -2.8M -10,910 -- --
Tax Rate For Calcs 0.00 0.00 0.00 0.00
Normalized Income -5.1M -4.6M -706,206 -3.2M
Depreciation Amortization Depletion Income Statement 707,256 512,827 364,552 295,808
Depreciation Income Statement 707,256 512,827 364,552 295,808
Diluted NI Availto Com Stockholders -7.9M -4.6M -706,206 -3.2M
Net Income Continuous Operations -7.9M -4.6M -706,206 -3.2M
Net Non Operating Interest Income Expense 39,952 -30,475 86,038 -30,530
Other Gand A 1.7M 1.1M 42,131 1.1M
Other Special Charges 2.8M 10,910 -- --
Other Taxes 0.00 -151,391 -445,023 -239,379
Salaries And Wages 2.6M 2.8M 666,297 1.8M
Total Expenses 5.2M 4.6M 792,244 3.2M
Line Item FY 2024Dec 31, 2024 FY 2023Dec 31, 2023 FY 2022Dec 31, 2022 FY 2021Dec 31, 2021
Cash And Cash Equivalents 1.5M 31,682 2.2M 4.8M
Cash Cash Equivalents And Short Term Investments 1.5M 31,682 2.2M 4.8M
Cash Equivalents 1.1M 0.00 -- --
Cash Financial 454,166 31,682 2.2M 4.8M
Other Short Term Investments -- 5.4M -- --
Accounts Receivable 0.00 264,139 4,419 0.00
Receivables 204,356 344,605 199,975 94,542
Prepaid Assets 99,417 76,647 51,856 22,979
Current Assets 1.8M 3.0M 2.8M 5.0M
Gross PPE 4.6M 4.0M 1.9M 1.5M
Accumulated Depreciation -1.5M -1.5M -996,923 -632,371
Net PPE 3.1M 2.5M 935,185 872,462
Total Non Current Assets 3.1M 2.5M 935,185 872,462
Total Assets 4.9M 5.4M 3.7M 5.8M
Current Debt -- 25,110 -- --
Current Debt And Capital Lease Obligation 215,026 373,340 107,892 147,865
Accounts Payable 208,947 361,662 112,577 14,064
Payables 208,947 361,662 112,577 14,064
Payables And Accrued Expenses 468,596 771,288 130,577 25,064
Current Accrued Expenses 259,649 409,626 18,000 11,000
Other Current Liabilities -- 2.5M -- --
Current Liabilities 683,622 3.6M 238,469 172,929
Long Term Debt And Capital Lease Obligation 1.3M 1.4M 0.00 107,892
Long Term Capital Lease Obligation 1.3M 1.4M 0.00 107,892
Total Non Current Liabilities Net Minority Interest 1.3M 1.4M 0.00 107,892
Total Liabilities Net Minority Interest 2.0M 5.1M 238,469 280,821
Common Stock 25.3M 16.2M 15.4M 14.3M
Capital Stock 25.3M 16.2M 15.4M 14.3M
Retained Earnings -26.6M -19.1M -14.5M -10.8M
Gains Losses Not Affecting Retained Earnings 4.2M 3.3M 2.5M 2.0M
Common Stock Equity 2.9M 372,830 3.5M 5.6M
Stockholders Equity 2.9M 372,830 3.5M 5.6M
Total Equity Gross Minority Interest 2.9M 372,830 3.5M 5.6M
Total Capitalization 2.9M 372,830 3.5M 5.6M
Net Tangible Assets 2.9M 372,830 3.5M 5.6M
Tangible Book Value 2.9M 372,830 3.5M 5.6M
Working Capital 1.1M -691,694 2.5M 4.8M
Invested Capital 2.9M 397,940 3.5M 5.6M
Total Debt 1.5M 1.8M 107,892 255,757
Share Issued 53.9M 53.8M 53.8M 53.8M
Ordinary Shares Number 53.9M 53.8M 53.8M 53.8M
Accrued Interest Receivable 10,092 0.00 -- --
Buildings And Improvements 1.8M 2.5M -- --
Capital Lease Obligations 1.5M 1.8M 107,892 255,757
Current Capital Lease Obligation 215,026 348,230 107,892 147,865
Current Deferred Assets 0.00 42,525 -- --
Current Notes Payable 0.00 25,110 -- --
Hedging Assets Current -- -- 256,500 --
Leases 1.0M 53,300 -- --
Loans Receivable -- 25,000 -- --
Machinery Furniture Equipment 497,564 272,052 248,850 103,012
Other Equity Interest -- 1.1M -- --
Other Properties 1.3M 1.2M 1.7M 1.4M
Properties 0.00 0.00 -- --
Restricted Cash 0.00 2.5M -- --
Taxes Receivable 194,264 80,466 195,556 94,542
Line Item FY 2024Dec 31, 2024 FY 2023Dec 31, 2023 FY 2022Dec 31, 2022 FY 2021Dec 31, 2021
Operating Cash Flow -4.8M -2.9M -46,472 -3.0M
Cash Flow From Continuing Operating Activities -4.8M -2.9M -46,472 -3.0M
Depreciation And Amortization 707,256 512,827 364,552 295,808
Depreciation Amortization Depletion 707,256 512,827 364,552 295,808
Stock Based Compensation 0.00 821,059 666,297 53,256
Change In Working Capital -304,313 432,100 -72,870 -146,994
Changes In Account Receivables 254,047 -149,720 -114,418 0.00
Change In Receivables 140,249 -144,630 -85,681 -25,574
Change In Payables And Accrued Expense -422,682 601,521 -7,972 -111,491
Other Non Cash Items 2.7M 11,020 66,307 1,000
Capital Expenditure -1.3M -162,086 -380,808 -333,075
Purchase Of PPE -1.3M -162,086 -380,808 -333,075
Net PPE Purchase And Sale -1.3M -162,086 -380,808 -333,075
Sale Of Business 5.2M 0.00 -- --
Purchase Of Investment -- -5.5M -5.3M --
Sale Of Investment -- 5.5M 775,000 --
Net Investment Purchase And Sale -- -57,545 -4.5M --
Investing Cash Flow 6.3M -2.6M -4.5M -333,075
Cash Flow From Continuing Investing Activities 6.3M -2.6M -4.5M -333,075
Issuance Of Debt 225,000 25,000 -- --
Repayment Of Debt -261,197 -211,461 -147,865 -130,620
Net Issuance Payments Of Debt -36,197 -186,461 -147,865 -130,620
Issuance Of Capital Stock 0.00 522,687 5.0M 6.6M
Net Common Stock Issuance 0.00 522,687 5.0M 6.6M
Financing Cash Flow -59,948 3.3M 4.4M 6.6M
Cash Flow From Continuing Financing Activities -59,948 3.3M 4.4M 6.6M
Changes In Cash 1.5M -2.2M -117,608 3.2M
Beginning Cash Position 31,682 2.2M 187,110 1.6M
End Cash Position 1.5M 31,682 69,502 4.8M
Free Cash Flow -6.1M -3.0M -46,472 -3.4M
Interest Paid Supplemental Data 102,208 4,643 20,136 30,530
Change In Prepaid Assets -21,880 -24,791 20,783 -9,929
Common Stock Issuance 0.00 522,687 5.0M 6.6M
Depreciation 707,256 512,827 364,552 295,808
Interest Received Cfi -- 213,577 42,295 --
Long Term Debt Payments -261,197 -211,461 -147,865 -130,620
Net Business Purchase And Sale 5.2M 0.00 -- --
Net Income From Continuing Operations -7.9M -4.6M -706,206 -3.2M
Net Long Term Debt Issuance -261,197 -211,461 -147,865 -130,620
Net Other Financing Charges -28,751 2.5M -588,431 -91,310
Net Other Investing Changes 2.5M -2.5M -- --
Net Short Term Debt Issuance 225,000 25,000 -- --
Proceeds From Stock Option Exercised 5,000 472,150 0.00 215,050
Short Term Debt Issuance 225,000 25,000 -- --
NEWS
Loading news...
TRENDING
Loading...